Insulet Corporation is a medical device company specializing in the design, development and manufacture of tubeless insulin delivery systems. With a focus on simplifying diabetes management, Insulet markets its flagship Omnipod product line, which includes wearable, disposable insulin pods and accompanying handheld controllers. The company’s mission centers on improving the lives of people with insulin-dependent diabetes through user-friendly, technology-driven solutions.
The Omnipod System consists of a small, waterproof pod that adheres directly to the skin and delivers continuous subcutaneous insulin via preset dosing, along with a personal diabetes manager (PDM) that wirelessly programs and monitors insulin delivery. Insulet has expanded its product portfolio to include the Omnipod DASH® Insulin Management System and the Omnipod 5 Automated Insulin Delivery System, which integrates with continuous glucose monitoring (CGM) sensors to adjust insulin dosing in real time. The company also provides mobile applications and cloud‐based platforms to support data sharing and remote patient monitoring.
Founded in 2000 and headquartered in Acton, Massachusetts, Insulet went public in 2007 and has since grown into a global organization serving customers across North America, Europe, Australia, Japan and other international markets. Insulet oversees its own manufacturing facilities and collaborates with third‐party partners to ensure a consistent supply of high-quality pods and electronic components. The company invests heavily in research and development to drive next-generation features, enhance user experience and expand indications for its technology.
Under the leadership of President and Chief Executive Officer John Freda, Insulet emphasizes a patient-centric culture and strategic expansion into new geographies and clinical applications. The management team combines expertise in medical technology, regulatory affairs and commercial operations to guide the company’s long-term growth. Through continuous innovation and a commitment to simplifying insulin delivery, Insulet aims to set new standards in diabetes care and support better outcomes for people living with diabetes.
AI Generated. May Contain Errors.
